The Role of Insulin in the Critically Ill Patient: Basic and Clinical Evidence

 

December 9, 2004

Natcher Conference Center
Main Auditorium
National Institutes of Health
Bethesda, Maryland

Focus
Registration
Agenda
Speakers
Travel
Contact

Preliminary Program

Thursday, December 9, 2004


7:30 am
Registration

8:20 am
Welcome and Introduction
Allen M. Spiegel, MD


SESSION I: CLINICAL SCIENCE

Chairs: Claresa Levetan, MD and Howard Baum, MD


8:30 - 9:05 am
Intensive insulin therapy in the ICU
Greet Van den Berghe, MD, PhD

9:05 - 9:10 am
Questions and Answers

9:10 - 9.45 am
Glucose regulation in diabetic patients with acute coronary syndromes
Klas Malmberg, MD, PhD

9:45 - 9:50 pm
Questions and Answers

9:50 - 10:20 am
BREAK

10:20 - 10:55 am
Clinical experience of implementing tight glucose control
Jeremy Cordingley, MD

10:55 - 11:00 am
Questions and Answers

11:00 - 11:35 am
The impact of hyperglycemia and insulin infusions on cardiac surgery outcomes: The Portland Diabetic Project
Anthony Furnary, MD

11:35 - 11:40 am
Questions and Answers

11:40 - 12:40 pm
LUNCH



Top of page



SESSION II: BASIC SCIENCE

Chairs: R. Smith, MD and Nathaniel Clark, MD

12:40 - 1:20 pm
The anti-inflammatory and anti-atherogenic effect of insulin!
Paresh Dandona, MD, PhD

1:20 - 1:25 pm
Questions and Answers

1:25 - 2:05 pm
Pro-atherosclerotic effects of insulin resistance and hyperinsulinemia
Boris Draznin, MD

2:05 - 2:10 pm
Questions and Answers

2:10 - 2:25 pm
BREAK

2:25 - 3.05 pm
Endothelial NO
Michael Quon, MD, PhD

3:05 - 3:10pm
Questions and Answers

3:10 - 3:50 pm
Nuclear receptors in the etiology and treatment of Syndrome X
Ronald Evans, PhD

3:50 - 3:55 pm
Questions and Answers

3:55 - 4:10 pm
Summary
Jesse Roth, MD

4:10 - 5:10 pm
Roundtable discussion




NIDDK logo National Institute of Diabetes and Digestive and Kidney Diseases



Top of page




 

The Role of Insulin in the Critically Ill Patient: Basic and Clinical Evidence